NovaBay Pharmaceuticals, Inc.
General ticker "NBY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $4.7M (TTM average)
NovaBay Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 29.8%.
Estimated limits based on current volatility of 4.1%: low 1.01$, high 1.10$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-09-15, amount 0.80$ (Y73.39%)
- Total employees count: 28 as of 2007
- Current price 26.8% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.84$, 10.58$]
- 2024-12-30 to 2025-12-30 estimated range: [1.49$, 5.66$]
Financial Metrics affecting the NBY estimates:
- Negative: with PPE of -0.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -421.53 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 36.68 <= 41.86
- Negative: negative Net income
Short-term NBY quotes
Long-term NBY plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $10.20MM | $14.40MM | $10.46MM |
| Operating Expenses | $19.07MM | $28.82MM | $14.56MM |
| Operating Income | $-8.86MM | $-14.42MM | $-4.10MM |
| Non-Operating Income | $3.04MM | $3.81MM | $-2.04MM |
| Interest Expense | $0.00MM | $0.00MM | $1.69MM |
| R&D Expense | $0.04MM | $0.17MM | $0.03MM |
| Income(Loss) | $-5.82MM | $-10.61MM | $-6.14MM |
| Profit(Loss)* | $-5.82MM | $-10.61MM | $-9.64MM |
| Stockholders Equity | $10.17MM | $10.55MM | $3.31MM |
| Inventory | $3.22MM | $3.44MM | $2.88MM |
| Assets | $23.98MM | $16.40MM | $9.03MM |
| Operating Cash Flow | $-9.19MM | $-6.65MM | $-4.13MM |
| Capital expenditure | $0.05MM | $0.11MM | $0.02MM |
| Investing Cash Flow | $-12.04MM | $-0.11MM | $-0.02MM |
| Financing Cash Flow | $16.79MM | $4.63MM | $1.91MM |
| Earnings Per Share** | $-184.09 | $-353.59 | $-80.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.